<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Synergy Pharmaceuticals Inc - Google Finance</title>
<description>News for Synergy Pharmaceuticals Inc - Google Finance</description>
<link>http://www.google.com/finance?q=NASDAQ:SGYP&amp;amp;client=news-rss&amp;amp;ei=XaWcUeiGKoW40gGBogE</link>
<image>
<title>News for Synergy Pharmaceuticals Inc - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NASDAQ:SGYP&amp;amp;client=news-rss&amp;amp;ei=XaWcUeiGKoW40gGBogE</link>
</image>
<item>
<title>Synergy Pharmaceuticals Presents Plecanatide Results From a Large ...</title>
<link>http://www.globenewswire.com/news-release/2013/05/21/548747/10033193/en/Synergy-Pharmaceuticals-Presents-Plecanatide-Results-From-a-Large-Multicenter-Clinical-Study-at-Late-Breaking-Abstract-Session-During-Digestive-Disease-Week-2013.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982068564596</guid>
<pubDate>Tue, 21 May 2013 14:00:31 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.globenewswire.com/news-release/2013/05/21/548747/10033193/en/Synergy-Pharmaceuticals-Presents-Plecanatide-Results-From-a-Large-Multicenter-Clinical-Study-at-Late-Breaking-Abstract-Session-During-Digestive-Disease-Week-2013.html&quot; style=&quot;font-size:1.2em&quot;&gt;Synergy Pharmaceuticals Presents Plecanatide Results From a Large ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GlobeNewswire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;21 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;NEW YORK, May 21, 2013 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat patients with gastrointestinal disorders and diseases, today presented positive safety and efficacy results from its large ...&lt;/div&gt;
&lt;a href=&quot;http://www.bizjournals.com/philadelphia/news/2013/05/21/study-results-positive-for.html&quot;&gt;Constipation therapy gets moving&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Philadelphia Business Journal&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://seekingalpha.com/article/1450541-synergy-is-a-straightforward-opportunity-trial-results-at-ddw-back-plecanatide?source=google_news&quot;&gt;Synergy Is A Straightforward Opportunity: Trial Results At DDW Back Plecanatide&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Seeking Alpha&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Bearish MACD for Synergy Pharmaceuticals Inc.</title>
<link>http://www.zacks.com/stock/news/98020/bearish-macd-for-synergy-pharmaceuticals-inc</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778132693374</guid>
<pubDate>Fri, 26 Apr 2013 15:24:04 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.zacks.com/stock/news/98020/bearish-macd-for-synergy-pharmaceuticals-inc&quot; style=&quot;font-size:1.2em&quot;&gt;Bearish MACD for Synergy Pharmaceuticals Inc.&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Zacks.com&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 26, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Synergy Pharmaceuticals Inc.&amp;#39;s ( SGYP - Snapshot Report ) MACD indicator has moved into bearish territory with a reading of –0.2917.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index - NASDAQ.com</title>
<link>http://www.nasdaq.com/article/synergy-pharmaceuticals-added-to-nasdaq-biotechnology-index-20130514-00389</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982061327408</guid>
<pubDate>Tue, 14 May 2013 12:33:30 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.nasdaq.com/article/synergy-pharmaceuticals-added-to-nasdaq-biotechnology-index-20130514-00389&quot; style=&quot;font-size:1.2em&quot;&gt;Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index - NASDAQ.com&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;NASDAQ (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index ® (Nasdaq:^NBI), ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results</title>
<link>http://www.globenewswire.com/news-release/2013/05/09/546072/10032297/en/Synergy-Pharmaceuticals-Reports-First-Quarter-2013-Financial-Results.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778149259967</guid>
<pubDate>Thu, 09 May 2013 21:28:21 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.globenewswire.com/news-release/2013/05/09/546072/10032297/en/Synergy-Pharmaceuticals-Reports-First-Quarter-2013-Financial-Results.html&quot; style=&quot;font-size:1.2em&quot;&gt;Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GlobeNewswire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 9, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;NEW YORK, May 9, 2013 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results and business update for the first quarter ended ...&lt;/div&gt;
&lt;a href=&quot;http://www.4-traders.com/news/Synergy-Pharmaceuticals-Inc-Synergy-Pharmaceuticals-Chief-Scientific-Officer-to-Give-Plenary-Lec--16836857/&quot;&gt;SYNERGY PHARMACEUTICALS INC. : Synergy Pharmaceuticals&amp;#39; Chief ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;4-traders (press release)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Seabridge Gold Inc. (USA) (NYSE:SA) down by 6.60%, Synergy ...</title>
<link>http://www.nismagazine.com/seabridge-gold-inc-usa-nysesa-down-by-6-60-synergy-pharmaceuticals-inc-nasdaqsgyp/126436/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.nismagazine.com/seabridge-gold-inc-usa-nysesa-down-by-6-60-synergy-pharmaceuticals-inc-nasdaqsgyp/126436/</guid>
<pubDate>Thu, 16 May 2013 06:47:21 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.nismagazine.com/seabridge-gold-inc-usa-nysesa-down-by-6-60-synergy-pharmaceuticals-inc-nasdaqsgyp/126436/&quot; style=&quot;font-size:1.2em&quot;&gt;Seabridge Gold Inc. (USA) (NYSE:SA) down by 6.60%, Synergy ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;NIS&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Synergy Pharmaceuticals Inc (NASDAQ:SGYP) traded down by 3.58% to $5.11, with total traded volumes of 0.940 million in comparison to its average volume of 1.60 million shares.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>NASDAQ Decliners Watch List: Mecox Lane Limited (NASDAQ:MCOX) and ...</title>
<link>http://www.sbwire.com/press-releases/nasdaq-decliners-watch-list-mecox-lane-limited-nasdaqmcox-and-synergy-pharmaceuticals-inc-nasdaqsgyp-added-to-growing-stock-reports-nasdaq-decliners-watch-list-241743.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778127312577</guid>
<pubDate>Wed, 24 Apr 2013 12:18:58 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/nasdaq-decliners-watch-list-mecox-lane-limited-nasdaqmcox-and-synergy-pharmaceuticals-inc-nasdaqsgyp-added-to-growing-stock-reports-nasdaq-decliners-watch-list-241743.htm&quot; style=&quot;font-size:1.2em&quot;&gt;NASDAQ Decliners Watch List: Mecox Lane Limited (NASDAQ:MCOX) and ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;New York, NY -- (SBWIRE) -- 04/24/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Mecox Lane Limited (NASDAQ:MCOX) and Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP). Mecox Lane Limited (NASDAQ:MCOX) ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Stocks Recap: II-VI, Synergy Pharmaceuticals Inc, Ryder System, Arch Coal Inc</title>
<link>http://www.sbwire.com/press-releases/stocks-recap-ii-vi-synergy-pharmaceuticals-inc-ryder-system-arch-coal-inc-242156.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778130708693</guid>
<pubDate>Wed, 24 Apr 2013 16:52:46 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/stocks-recap-ii-vi-synergy-pharmaceuticals-inc-ryder-system-arch-coal-inc-242156.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Stocks Recap: II-VI, Synergy Pharmaceuticals Inc, Ryder System, Arch Coal Inc&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;II-VI, Inc.(NASDAQ:IIVI) decreased 12.03% and closed at $14.85 on a traded volume of 1.90 million shares.The Company announced third quarter results. Bookings for the quarter decreased 4% to $140,332,000. Revenues for the quarter increased 9% to ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Stocks In News (HomeAway, Synergy Pharmaceuticals Inc, IAMGOLD ...</title>
<link>http://www.meshpress.com/stocks-in-news-homeaway-synergy-pharmaceuticals-inc-iamgold-corporation-gilead-sciences/1235702.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778131845902</guid>
<pubDate>Thu, 25 Apr 2013 12:25:50 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.meshpress.com/stocks-in-news-homeaway-synergy-pharmaceuticals-inc-iamgold-corporation-gilead-sciences/1235702.html&quot; style=&quot;font-size:1.2em&quot;&gt;Stocks In News (HomeAway, Synergy Pharmaceuticals Inc, IAMGOLD ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Mesh Press (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;HomeAway, Inc. (NASDAQ:AWAY) shares declined 5.29% and closed at $32.02. The company, on April 23, reported its financial results for the first quarter ended March 31, 2013.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Investors Alert: Synergy Pharmaceuticals Inc, Service Corporation ...</title>
<link>http://www.sbwire.com/press-releases/investors-alert-synergy-pharmaceuticals-inc-service-corporation-international-royal-caribbean-cruises-ltd-spectrum-pharmaceuticals-243235.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778133168594</guid>
<pubDate>Fri, 26 Apr 2013 13:44:32 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/investors-alert-synergy-pharmaceuticals-inc-service-corporation-international-royal-caribbean-cruises-ltd-spectrum-pharmaceuticals-243235.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Investors Alert: Synergy Pharmaceuticals Inc, Service Corporation ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 26, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Synergy Pharmaceuticals Inc (NASDAQ:SGYP) shares gained 5.21% to $5.05. The company, on April 16, announced the closing of its underwritten public offering of 16,375,000 shares of common stock at an offering price of $5.50 per share.&lt;/div&gt;
&lt;a href=&quot;http://www.therem.org/5-small-cap-stocks-catching-attention-examworks-icon-plc-silvercorp-metals-ambarella-arena-pharmaceuticals-synergy-pharmaceuticals/123439/&quot;&gt;5 Small-Cap Stocks Catching Attention: Examworks, ICON plc, Silvercorp Metals ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;REM&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Investors Buzz: Synergy Pharmaceuticals, National Penn Bancshares, Fairchild ...</title>
<link>http://www.sbwire.com/press-releases/investors-buzz-synergy-pharmaceuticals-national-penn-bancshares-fairchild-semiconductor-qep-resources-241067.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.sbwire.com/press-releases/investors-buzz-synergy-pharmaceuticals-national-penn-bancshares-fairchild-semiconductor-qep-resources-241067.htm</guid>
<pubDate>Mon, 22 Apr 2013 18:16:40 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/investors-buzz-synergy-pharmaceuticals-national-penn-bancshares-fairchild-semiconductor-qep-resources-241067.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Investors Buzz: Synergy Pharmaceuticals, National Penn Bancshares, Fairchild ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 22, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Synergy Pharmaceuticals Inc (NASDAQ:SGYP) shares declined 2.55% to $4.96. The company, on April 16, announced the closing of its underwritten public offering of 16,375,000 shares of common stock at an offering price of $5.50 per share.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
